All In Biotech

Free tool

FAERS Monitor: Jesduvroq

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 216951 or its brand name (Jesduvroq, Daprodustat). Reports on generic versions are filed under their own applications.

Reports

1,993

Serious

1,889

95% of reports

Hospitalization

1,051

Death reported

439

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • hospitalisation299
  • off label use166
  • product use issue160
  • death118
  • haemoglobin decreased102
  • renal impairment97
  • cardiac failure94
  • haemoglobin increased85
  • dysphagia83
  • nephrogenic anaemia73
  • marasmus64
  • cerebral infarction59
  • fall57
  • pneumonia51
  • condition aggravated42

Reports by year received

View as table
YearReports
20172
201823
201920
202012
202153
202247
2023550
2024487
2025489
2026310

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,052,166 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
marasmusSignal64464.0362.627,884
haemoglobin increasedSignal85200.4162.416,356
nephrogenic anaemiaSignal73169.0134.611,834
cerebral infarctionSignal5925.519.91,365
hospitalisationSignal29920.618.55,579
cardiac failureSignal9412.410.2974
renal impairmentSignal9712.210.0989
haemoglobin decreasedSignal10210.58.7870
dysphagiaSignal839.27.5603
product use issueSignal1609.07.71,138
off label useSignal1662.01.786
fall571.81.420
pneumonia511.71.313
condition aggravated421.51.16
death1181.41.216

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.